Researchers have developed a statistical model that predicts the likelihood of female childhood cancer survivors developing premature menopause as they grow up, which could help doctors personalize treatment and counseling ...
Mar 19, 2024
0
11
Researchers have shown for the first time that a crucial interface in a protein that drives cancer growth could act as a target for more effective treatments.
Mar 19, 2024
0
47
While heavy drinking is a well-established risk factor for liver cancer, the specific mechanisms by which alcohol contributes to A-HCC remain unclear.
7 hours ago
0
0
A systemic review of the current body of research shows that investigators have inadequately addressed the intersection of aging, health disparities, and cancer outcomes among older adults. This is the conclusion of a paper ...
10 hours ago
0
19
An innovative health care program developed by researchers at the University of Ottawa has successfully paired residents with family physicians at a time when Canada is lagging behind comparable, high-income countries in ...
Apr 18, 2024
0
1
Non-small cell lung cancer accounts for nearly 85% of all lung cancer cases. Targeted immunotherapy is a common treatment, but it does not work for everyone. However, a new Moffitt Cancer Center study published in the journal ...
Apr 18, 2024
0
4
Diagnosis and treatment of breast cancer place significant stress on survivors, their partners, and their relationships. A new study from researchers with Regenstrief Institute and Indiana University's Schools of Nursing, ...
Apr 18, 2024
0
1
University of Hawaiʻi Cancer Center researchers have conducted a phase II clinical trial investigating the potential of pembrolizumab maintenance therapy, a type of immunotherapy, in aggressive forms of breast cancer. The ...
Apr 18, 2024
0
9
A new study has found that by offering stop-smoking support as part of the national lung cancer screening program, there is potential to save lives, and dedicated funding must be considered by policymakers.
Apr 18, 2024
0
0
For the first time in fifty years, results from a Phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.
Apr 17, 2024
0
1
